Preservation of autonomic function following successful reperfusion with strepfokinase within 12 hours of the onset of acute myocardial infarction

American Journal of Cardiology

Volumn 79, Issue 2, 1997, Pages 203-205

  Kelly, Paul A ^a   Nolan, James ^b   Wilson, J Ian ^b   Perrins, E John ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; MYOGLOBIN; STREPTOKINASE;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD; CORONARY BLOOD VESSEL; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; REPRODUCIBILITY; SURVIVAL RATE; TIME; VASCULAR PATENCY;

AUTONOMIC NERVOUS SYSTEM; CORONARY VESSELS; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FIBRINOLYTIC AGENTS; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MYOCARDIAL INFARCTION; MYOGLOBIN; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; STREPTOKINASE; SURVIVAL RATE; THROMBOLYTIC THERAPY; TIME FACTORS; VASCULAR PATENCY;

EID: 0031567868     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00715-1     Document Type: Article

References (20)

1. Flapan AD, Wright RA, Nolan J, Nailson JMM, Ewing DJ. Differing patterns of cardiac parasympathetic activity and their evolution in selected patients with a first myocardial infarction. J Am Coll Cardiol 1993;21:926-931.
2. Nolan J, Flapan AD, Goodfield NE, Prescott RJ, Bloomfield P, Neilson JMM, Ewing DJ. Measurement of parasympathetic activity from 24 hour ambulatory electrocardiograms and its reproducibility and sensitivity in normal subjects, patients with symptomatic myocardial ischaemia, and patients with diabetes mellitus. Am J Cardiol 1996;77:154-158.
3. Kleiger RE, Miller JP, Bigger JT, Moss AJ, the Multicenter Postinfarction Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-262.
4. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-171.
5. Fibrinolytic Therapy Trialists Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:3117-322.
6. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after myocardial infarction. N Engl J Med 1993;329:673-682.
7. Pedretti REE, Colombo E, Braga SS, Caru B. Effect of thrombolysison heart rate variability and life-threatening ventricular arrhythmias in survivors of acute myocardial infarction. J Am Coll Cardiol 1994;23:19-26.
8. Molgaard H. Evaluation of the Reynolds Pathfinder II system for 24h heart rate variability analysis. Eur Heart J 1991;12:1153-1162.
9. Malliani A, Ragani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:482-492.
10. Xia R, Odemuyiwa O, Murgatroyd F, Gill J, Malik M, Camm AJ. Influence of recognition errors of computerised analysis of 24 hour electrocardiograms on the measurement of spectral components of heart rate variability, Int J Biomed Comput 1993;32:223-235.
11. Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate variability: a measure of cardiac autonomic tone. Am Heart J 1994;127:1376-1381.
12. Saran RK, Been M, Furniss SS, Hawkins T and Reid DS. Reduction in ST-segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function. Br Heart J 1990;64:113-117.
13. Hohnloser SH, Zabel M, Kasper W, Meinertz T, Just H. Assessment of coronary artery patency after thrombolytic therapy: Accurate prediction utilising the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991;18:44-49.
14. Baskin JM, Wilkins ML, Ohman EM, Clemmensen P, Grande P, Christenson RH, Sevilla DC, Wagner NB, Wagner GS. Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1993;71:1362-1365.
15. Batin PD, Nolan J. Assessment of autonomic function; reflex testing or variability analysis J Amb Mon (In press).
16. Schwartz PJ, La Rovere MT, Vanoli E. Autonomie nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1993;87:1220-1228.
17. Fei L, Slatters DJ, Huatkova K, Poloniecki J, Malik M, Camm AJ. Change of autonomic influence on the heart immediately before the onset of spontaneous idiopathic ventricular tachycardia. J Am Coll Cardiol 1994;24:1515-1522.
18. Schwartz PJ, Billman GE, Lowell Stone H. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischaemia during exercise in dogs with healed myocardial infarction: an experimental preparation for sudden death. Circulation 1984;69:790-800.
19. Odemuyiwa O, Farrell T, Staunton A, Sueddan J, Poloniecki J, Bennett D, Malik M, Camm J. Influence of thrombolytic therapy on the evolution of baro-reflex sensitivity after myocardial infarction. Am Heart J 1993;125:285-291.
20. Flapan AD, Nolan J, Neilson JMM, Ewing DJ. Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease. Am J Cardiol 1992;69:532-535.